Post-COVID-19 Chronic Fatigue Syndrome

Last updated: March 5, 2025
Sponsor: ClinAmygate
Overall Status: Completed

Phase

4

Condition

Covid-19

Treatment

Synthetic Vitamin B1

Clinical Study ID

NCT05642923
PR0012022
  • Ages > 18
  • All Genders

Study Summary

Fatigue is recognized as one of the most commonly presented long-term complaints in individuals previously infected with SARS-CoV-2.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age . 18

  • Male or female

  • Post-Covid-19 Fatigue

Exclusion

Exclusion Criteria:

  • refusal

Study Design

Total Participants: 528
Treatment Group(s): 1
Primary Treatment: Synthetic Vitamin B1
Phase: 4
Study Start date:
January 08, 2023
Estimated Completion Date:
March 05, 2025

Study Description

It has become increasingly clear that infected patients have symptoms not only in the acute phase, but also after recovery from the initial infection.

A recent meta-analysis including 4828 patients with post-COVID-19 showed that symptoms and post-acute sequelae of SARS-CoV-2 can persist weeks to months after the infection.

These patients who reported persistent symptoms have been termed "long haulers" or described as having long COVID, post-acute COVID-19, persistent COVID-19 symptoms, post COVID-19 manifestations, long-term COVID-19 effects, post-acute sequelae of COVID-19 (PASC), or post-COVID-19 syndrome.

Connect with a study center

  • Asalam

    Maadi, Cairo 11433
    Egypt

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.